|Day Low/High||0.05 / 0.05|
|52 Wk Low/High||0.01 / 0.14|
GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
Researchers complain the pot the government now supplies is of poor quality. The government contract is open for bidding, but growers say the hurdles are insurmountable.
Penny stock publisher Peter Leeds finds most pot companies to be very high risk and cautions investors to wait until prices drop.
Investing in hot growth stocks at high prices often ends badly.
Cannabis Science Inc (NASD OTC: CBIS) and the World AIDS Institute announced today the appointment of Robert Melamede, PhD, Professor of Biology at the University of Colorado, Colorado Springs and CEO of Cannabis...
Cannabis Science (NASD OTC: CBIS), a pioneering U.S.
Cannabis Science Inc., (CBIS) announced today the appointment of Ronald Sekura PH.
Cannabis Science (CBIS) announced today the appointment of J. Thomas August, MD, Professor, Pharmacology and Molecular Sciences, and Oncology, The Johns Hopkins School of Medicine, to the Company’s Scientific...
Cannabis Science ( CBIS), a pioneering U.S.
Cannabis Science Inc. (OTCBB:CBIS) announced today the presentation on the effects of phytocannabinoid inhibition on HIV TAT at the World AIDS Institute Treatment Horizons Satellite Symposium during AIDS 2012 in ...
Cannabis Science (OTCBB:CBIS), a pioneering U.S.
Cannabis Science Inc., (CBIS) on Friday, July 20th Robert Melamede PhD, CEO of Cannabis Science presented at the Treatment Horizons Briefing at the Rayburn Legislative Office Building in Washington D.
Cannabis Science Inc (OTCBB: CBIS) announced the appointment of Mariel Selbovitz, MPH as Vice President of Research Program Development, reflecting the maturing direction of the company with the initiation of the...
Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce Strategic Health Resources LLC, an Arlington, VA-based biomedical and health...
Cannabis Science, Inc. (CBIS), a pioneering U.
Cannabis Science Inc (CBIS) announced today the appointment of Dorothy Bray, Ph.
Cannabis Science (CBIS), a pioneering U.S.
Dr. Robert Melamede, President and CEO of Cannabis Science (CBIS), announced today that Roscoe Moore, DVM, PhD, MPH has been appointed to the Scientific Advisory Board.
Dr. Robert Melamede, President and CEO of Cannabis Science (CBIS.
Cannabis Science (CBIS.OB) announced today the initiation of a research program to explore the commercial development of Phytocannabinoid-based therapeutics for drug resistant HIV infection.
Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.